Wingate's Pharmacy and Compounding
483 response sent March 3, 2016 · Stoneham, Massachusetts
- Inspection
- Feb 1 – Feb 19, 2016
- Investigator
- Stacey S. Degarmo
- Pages
- 12
In short: This is Wingate's Pharmacy and Compounding's written response to FDA, dated March 3, 2016, for its site in Stoneham, Massachusetts. It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Stacey S. Degarmo
10 documents · 2010–2016
Cites 211.42 (design and construction features) more than any other section. Most of their documents are for sites in Massachusetts.
The firmWingate's Pharmacy and Compounding history
The site's inspection history, in date order.
Similar documentsMore 483 responses
Browse other documents of this type.
Questions about this response
Who inspected Wingate's Pharmacy and Compounding?
Stacey S. Degarmo is named on this 483 response, for the inspection of Feb 1 – Feb 19, 2016. Each investigator has a profile showing what they cite most.
When was Wingate's Pharmacy and Compounding inspected by FDA?
The inspection ran Feb 1 – Feb 19, 2016, and the 483 response is dated March 3, 2016.
How do I get the full 483 response for Wingate's Pharmacy and Compounding?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.